Racial Disparities in Kidney Disease Outcomes

Seminars in Nephrology

Volumn 33, Issue 5, 2013, Pages 409-415

  Nicholas, Susanne B ^a,b   Kalantar Zadeh, Kamyar ^c   Norris, Keith C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chronic kidney disease; Racial disparities

Indexed keywords

ALBUMINURIA; ARTICLE; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; EPIDEMIC; ETHNIC DIFFERENCE; ETHNICITY; GLOMERULUS FILTRATION RATE; HEALTH CARE ACCESS; HEALTH CARE DISPARITY; HEALTH PROMOTION; HUMAN; KIDNEY FAILURE; MEDICARE; NEPHRITIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RACE DIFFERENCE; RACISM; RISK FACTOR; SOCIAL ASPECT; SURVIVAL RATE;

CHRONIC KIDNEY DISEASE; RACIAL DISPARITIES;

HEALTH SERVICES ACCESSIBILITY; HEALTH STATUS DISPARITIES; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC;

EID: 84885205093     PISSN: 02709295     EISSN: 15584488     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2013.07.002     Document Type: Article

References (39)

1. Coresh J., Selvin E., Stevens L.A., et al. Prevalence of chronic kidney disease in the United States. JAMA 2007, 298:2038-2047.
2. Collins A.J., Foley R.N., Herzog C., et al. US Renal Data System 2012 annual data report. Am J Kidney Dis 2013, 61:A7.
3. Collins A.J., Foley R.N., Herzog C., et al. US Renal Data System 2010 annual data report. Am J Kidney Dis 2011, 57:A8:e1-526.
4. Norris K., Nissenson A.R. Race, gender, and socioeconomic disparities in CKD in the United States. J Am Soc Nephrol 2008, 19:1261-1270.
5. Norris K.C., Agodoa L.Y. Unraveling the racial disparities associated with kidney disease. Kidney Int 2005, 68:914-924.
6. Powe N.R. To have and have not: health and health care disparities in chronic kidney disease. Kidney Int 2003, 64:763-772.
7. Powe N.R. Let's get serious about racial and ethnic disparities. J Am Soc Nephrol 2008, 19:1271-1275.
8. Freedman B.I., Kopp J.B., Langefeld C.D., et al. The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. J Am Soc Nephrol 2010, 21:1422-1426.
9. Genovese G., Friedman D.J., Ross M.D., et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010, 329:841-845.
10. Streja E., Kovesdy C.P., Molnar M.Z., et al. Role of nutritional status and inflammation in higher survival of African American and Hispanic hemodialysis patients. Am J Kidney Dis 2011, 57:883-893.
11. Crews D.C., Sozio S.M., Liu Y., Coresh J., Powe N.R. Inflammation and the paradox of racial differences in dialysis survival. J Am Soc Nephrol 2011, 22:2279-2286.
12. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1-266.
13. Levey A.S., Atkins R., Coresh J., et al. Chronic kidney disease as a global public health problem: approaches and initiatives--a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 2007, 72:247-259.
14. McCullough P.A., Steigerwalt S., Tolia K., et al. Cardiovascular disease in chronic kidney disease: data from the Kidney Early Evaluation Program (KEEP). Curr Diab Rep 2011, 11:47-55.
15. Rostand S.G., Kirk K.A., Rutsky E.A., Pate B.A. Racial differences in the incidence of treatment for end-stage renal disease. N Engl J Med 1982, 306:1276-1279.
16. Hsu C.Y., Lin F., Vittinghoff E., Shlipak M.G. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol 2003, 14:2902-2907.
17. Owen W.F., Chertow G.M., Lazarus J.M., Lowrie E.G. Dose of hemodialysis and survival: differences by race and sex. JAMA 1998, 280:1764-1768.
18. Hopson S., Frankenfield D., Rocco M., McClellan W. Variability in reasons for hemodialysis catheter use by race, sex, and geography: findings from the ESRD Clinical Performance Measures Project. Am J Kidney Dis 2008, 52:753-760.
19. Reddan D., Klassen P., Frankenfield D.L., et al. National profile of practice patterns for hemodialysis vascular access in the United States. J Am Soc Nephrol 2002, 13:2117-2124.
20. Kalantar-Zadeh K., Golan E., Shohat T., Streja E., Norris K.C., Kopple J.D. Survival disparities within American and Israeli dialysis populations: learning from similarities and distinctions across race and ethnicity. Semin Dial 2010, 23:586-594.
21. Kovesdy C.P., Anderson J.E., Derose S.F., Kalantar-Zadeh K. Outcomes associated with race in males with nondialysis-dependent chronic kidney disease. Clin J Am Soc Nephrol 2009, 4:973-978.
22. Davey Smith G., Neaton J.D., Wentworth D., Stamler R., Stamler J. Mortality differences between black and white men in the USA: contribution of income and other risk factors among men screened for the MRFIT. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Lancet 1998, 351:934-939.
23. Kucirka L.M., Grams M.E., Lessler J., et al. Association of race and age with survival among patients undergoing dialysis. JAMA 2011, 306:620-626.
24. Vaziri N.D., Norris K.C. Reasons for the lack of salutary effects of cholesterol-lowering interventions in end-stage renal disease populations. Blood Purif 2013, 35:31-36.
25. Kalantar-Zadeh K., Kovesdy C.P., Norris K.C. Racial survival paradox of dialysis patients: robust and resilient. Am J Kidney Dis 2012, 60:182-185.
26. Noori N., Kovesdy C.P., Dukkipati R., et al. Racial and ethnic differences in mortality of hemodialysis patients: role of dietary and nutritional status and inflammation. Am J Nephrol 2011, 33:157-167.
27. Tarver-Carr M.E., Powe N.R., Eberhardt M.S., et al. Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors. J Am Soc Nephrol 2002, 13:2363-2370.
28. Gao S.W., Oliver D.K., Das N., et al. Assessment of racial disparities in chronic kidney disease stage 3 and 4 care in the department of defense health system. Clin J Am Soc Nephrol 2008, 3:442-449.
29. Weiner D.E., Tighiouart H., Amin M.G., et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004, 15:1307-1315.
30. Young B.A., Maynard C., Boyko E.J. Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans. Diabetes Care 2003, 26:2392-2399.
31. Wagner E.H. Chronic disease management: what will it take to improve care for chronic illness?. Eff Clin Pract 1998, 1:2-4.
32. Fahey T., Schroeder K., Ebrahim S. Educational and organisational interventions used to improve the management of hypertension in primary care: a systematic review. Br J Gen Pract 2005, 55:875-882.
33. Nolte E., McKee C.M. Measuring the health of nations: updating an earlier analysis. Health Aff (Millwood) 2008, 27:58-71.
34. Schroeder S.A. Shattuck lecture. We can do better--improving the health of the American people. N Engl J Med 2007, 357:1221-1228.
35. Marmot M., Friel S., Bell R., Houweling T.A., Taylor S. Closing the gap in a generation: health equity through action on the social determinants of health. Lancet 2008, 372:1661-1669.
36. Woolf S.H., Johnson R.E., Phillips R.L., Philipsen M. Giving everyone the health of the educated: an examination of whether social change would save more lives than medical advances. Am J Public Health 2007, 97:679-683.
37. Choi A.I., Weekley C.C., Chen S.C., et al. Association of educational attainment with chronic disease and mortality: the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 2011, 58:228-234.
38. Nicholas S., Agodoa L., Norris K. Ethnic disparities in the prevalence and treatment of kidney disease. Nephrol News Issues 2004, 18:29-30. 2, 4 passim.
39. Smedley B.D. Moving beyond access: achieving equity in state health care reform. Health Aff (Millwood) 2008, 27:447-455.